Condition: Lung Cancer · Quality of Life · Sponsor: University of Bayreuth
The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.
This description comes directly from the study's public registry record.
Martin Emmert, PhD, Prof. · +49 160 92203562 · martin.emmert@uni-bayreuth.de
Monika Klinkhammer-Schalke, MD, Prof. · +49-941-943-1803 · monika.klinkhammer-schalke@ur.de
Always discuss trial participation with your own doctor first.
| Klinikum Bamberg | Bamberg, Germany | Recruiting |
| Hospital Bayreuth | Bayreuth, Germany | Recruiting |
| Klinikum Coburg GmbH | Coburg, Germany | Recruiting |
| Caritas Krankenhaus St. Maria Donaustauf | Donaustauf, Germany | Recruiting |
| Klinikum Kulmbach | Kulmbach, Germany | Recruiting |
| Krankenhaus Barmherzige Brüder | Regensburg, Germany | Recruiting |
| Universitätsklinikum Regensburg | Regensburg, Germany | Recruiting |
| Klinikum St. Elisabeth Straubing | Straubing, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06252233